ATE45156T1 - Substituierte benzimidazole, verfahren zu ihrer herstellung und ihre anwendung zur hemmung der magensaeuresekretion. - Google Patents

Substituierte benzimidazole, verfahren zu ihrer herstellung und ihre anwendung zur hemmung der magensaeuresekretion.

Info

Publication number
ATE45156T1
ATE45156T1 AT85850341T AT85850341T ATE45156T1 AT E45156 T1 ATE45156 T1 AT E45156T1 AT 85850341 T AT85850341 T AT 85850341T AT 85850341 T AT85850341 T AT 85850341T AT E45156 T1 ATE45156 T1 AT E45156T1
Authority
AT
Austria
Prior art keywords
gastronic
inhibition
production
application
acid secretion
Prior art date
Application number
AT85850341T
Other languages
English (en)
Inventor
Kjell Fred Ankner
Arne Elof Braendstroem
Per Lennart Lindberg
Mats Peter Nordberg
Bjoern Morgan Gabriel Wallmark
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Application granted granted Critical
Publication of ATE45156T1 publication Critical patent/ATE45156T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT85850341T 1984-11-08 1985-10-25 Substituierte benzimidazole, verfahren zu ihrer herstellung und ihre anwendung zur hemmung der magensaeuresekretion. ATE45156T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8405588A SE8405588D0 (sv) 1984-11-08 1984-11-08 New compounds
EP85850341A EP0181846B1 (de) 1984-11-08 1985-10-25 Substituierte Benzimidazole, Verfahren zu ihrer Herstellung und ihre Anwendung zur Hemmung der Magensäuresekretion

Publications (1)

Publication Number Publication Date
ATE45156T1 true ATE45156T1 (de) 1989-08-15

Family

ID=20357660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85850341T ATE45156T1 (de) 1984-11-08 1985-10-25 Substituierte benzimidazole, verfahren zu ihrer herstellung und ihre anwendung zur hemmung der magensaeuresekretion.

Country Status (6)

Country Link
US (1) US4689331A (de)
EP (1) EP0181846B1 (de)
JP (1) JPH0633253B2 (de)
AT (1) ATE45156T1 (de)
DE (1) DE3571984D1 (de)
SE (1) SE8405588D0 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3527157A1 (de) * 1985-07-30 1987-02-12 Bayer Ag 1-heteroaryl-4-aryl-pyrazol-derivate
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
EP0304624A3 (de) * 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen
US5162317A (en) * 1988-05-12 1992-11-10 Esai Co., Ltd. Pyridinium salt and pharmacological composition containing the same
WO1992009595A1 (de) * 1990-11-29 1992-06-11 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue und bekannte disulfide und ihre verwendung
JPH07504176A (ja) * 1992-02-25 1995-05-11 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規及び公知のジスルフィド及びその使用
GB2447572B (en) 2005-11-17 2011-06-01 Jon Pty Ltd Pharmacologically active disulfide compounds
JP2010001281A (ja) * 2008-05-23 2010-01-07 Fujitsu Ltd 配位子、該配位子を含む金属錯体化合物及びその製造方法、並びに分子デバイスの製造方法
US8992897B2 (en) 2010-01-06 2015-03-31 Elc Management Llc Skin lightening compositions
US8722026B2 (en) 2010-01-06 2014-05-13 Elc Management, Llc Skin lightening compositions
US20130231372A1 (en) * 2012-03-01 2013-09-05 Mary Matsui Small Molecule Inhibitors Of P-type ATPases
CA2892620A1 (en) * 2012-11-26 2014-05-30 Emcure Pharmaceuticals Limited Pyridone derivatives as acid secretion inhibitors and process for preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE412587B (sv) * 1973-12-04 1980-03-10 Merck & Co Inc Forfarande for framstellning av substituerade imidazoler
US4182776A (en) * 1975-12-09 1980-01-08 American Cyanamid Company Method of treating lipidemia with aryloxyalkylaminobenzoic acids and esters
GB1584296A (en) * 1976-12-07 1981-02-11 Kanebo Ltd 2-substituted benzimidazole compounds
US4097603A (en) * 1977-09-06 1978-06-27 The Upjohn Company Gastric cytoprotection with non-antisecretory doses of prostaglandins
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB2038825B (en) * 1978-12-16 1983-02-09 Wyeth John & Brother Ltd Heterocyclic compounds substituted by heterocyclyl-alkyl-thio groups
US4327102A (en) * 1980-02-20 1982-04-27 John Wyeth & Brother Limited Certain 2-(phenyl sulfinylmethyl or ethyl) pyridine derivatives, composition containing same and method of using same
US4302464A (en) * 1980-10-16 1981-11-24 Pfizer Inc. Imidazolylpyridine therapeutic agents
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects

Also Published As

Publication number Publication date
DE3571984D1 (en) 1989-09-07
JPS61115080A (ja) 1986-06-02
EP0181846B1 (de) 1989-08-02
EP0181846A1 (de) 1986-05-21
SE8405588D0 (sv) 1984-11-08
US4689331A (en) 1987-08-25
JPH0633253B2 (ja) 1994-05-02

Similar Documents

Publication Publication Date Title
DE3483629D1 (de) 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IE940326L (en) Benzimidazole derivatives substituted with a radical group¹and their use for inhibiting gastric acid secretion
ATE45156T1 (de) Substituierte benzimidazole, verfahren zu ihrer herstellung und ihre anwendung zur hemmung der magensaeuresekretion.
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
ES8701752A1 (es) Un procedimiento para preparar derivados de bencimidazol
DE69027221D1 (de) Substituierte 4-phenyl-4-piperidincarboxamide mit sowohl lokalanästhetischer als auch schmerzlindernder wirkung sowie verfahren zur herstellung
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ES8800214A1 (es) Procedimiento para preparar derivados de bencimidazol substituidos
ATE56707T1 (de) Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
EP0173950A3 (de) Neuer alpha-Glukosidase Inhibitor, Verfahren zur seiner Herstellung, seine Verwendung und pharmazeutische Präparate
ES8802311A1 (es) Procedimiento de preparacion de derivados del triazol y de sus sales de adicion con los acidos apropiados
ATE48130T1 (de) Alpha-aryl-alpha-pyridylalkanoicsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE28647T1 (de) Chinazolinonderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ES8308562A1 (es) Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas
IE873144L (en) Substituted thienoimidazole-toluidine derivatives, a process¹for their preparation, pharmaceutical compositions¹containing them, and their use as inhibitors of gastric acid¹secretion
ATE41775T1 (de) Substituierte pyrido(1,2-c)imidazo((1,2a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
ES8306481A1 (es) Procedimiento para la obtencion de sulfamidas anulares.
PT82174A (de) Neue imidazolylverbindungen und verfahren zu ihrer herstellung
DE3576154D1 (de) 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung.
ATE12390T1 (de) Basisch substituierte anthranilsaeuren, verfahren zu ihrer herstellung und ihre verwendung.
ATE32063T1 (de) Iminosulfonamide und verfahren zu ihrer herstellung, die pharmazeutische praeparate solche verbindungen enthalten, sowie die verbindungen zur verwendung.
ATE33837T1 (de) Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3674250D1 (de) Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time